Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Zika Vaccine Clinical Trial Underway

The first of a series of clinical trials testing inactivated Zika particles as a vaccine to protect against the live Zika virus is recruiting participants. . . . → Read More: Zika Vaccine Clinical Trial Underway

Engineered Mosquito Production Facility Opens

A new industrial lab to produce mosquitoes genetically engineered to prevent the spread of infectious diseases opened in Piracicaba, Brazil. . . . → Read More: Engineered Mosquito Production Facility Opens

DoD Grant Funds Exosome Manufacturing Process

A biotechnology company is receiving a Department of Defense grant to develop a commercial-scale manufacturing process for exosomes, tiny bubbles that deliver drugs to cells in the body. . . . → Read More: DoD Grant Funds Exosome Manufacturing Process

Synthetic Viruses in Gene Therapy Licensed for Production

Techniques from academic research for developing synthetic viruses to deliver gene therapies are being licensed for commercial production and distribution. . . . → Read More: Synthetic Viruses in Gene Therapy Licensed for Production

Ordinary Smartphones Able to Hack 3-D Printers

A hacker with an everyday smartphone can steal design data from three-dimensional printers, according to a new paper from a university computer science group. . . . → Read More: Ordinary Smartphones Able to Hack 3-D Printers

Computer Models to Boost 3-D Print Designs in Mfring

An academic-industry team is developing computer-based methods to improve the design for three-dimensional printing of complex manufactured items. . . . → Read More: Computer Models to Boost 3-D Print Designs in Mfring

Stem Cells Banked for Bipolar Disorder Research

Stem cells from people with bipolar disorder are being collected by an academic-industry partnership for scientists worldwide who study the disorder. . . . → Read More: Stem Cells Banked for Bipolar Disorder Research

Portable On-Demand Biologic Production System Designed

A device that produces small batches of biological drugs, down to a single dose, was shown to generate two different biopharmaceuticals under lab conditions. . . . → Read More: Portable On-Demand Biologic Production System Designed

High-Volume, More Efficient Stem Cell Production Developed

An academic-industry team in Europe designed and tested new processes that can simplify and streamline production of human stem cells in large quantities. . . . → Read More: High-Volume, More Efficient Stem Cell Production Developed

Moderna, Merck Partner on Personal Cancer Vaccines

Scanning electron micrograph of a human T-cell lymphocyte (National Institute of Allergy and Infectious Diseases, NIH)

29 June 2016. Biotechnology company Moderna Therapeutics and drug maker Merck are developing therapeutic vaccines using messenger RNA that address unique genetic patterns in patients’ tumors. The deal is expected to bring Moderna an immediate payment of $200 . . . → Read More: Moderna, Merck Partner on Personal Cancer Vaccines